Improving Delirium Care in the ICU
Author Information
Author(s): Campbell Noll L, Khan Babar A, Farber Mark, Campbell Tiffany, Perkins Anthony J, Hui Siu L, Abernathy Greg, Buckley John, Sing Regg, Tricker Jason, Zawahiri Mohammad, Boustani Malaz A
Primary Institution: Regenstrief Institute, Inc.
Hypothesis
In comparison to usual care, intervention patients will have reduced delirium severity and fewer hospital days with delirium or coma.
Conclusion
The study aims to evaluate a pharmacological management protocol for delirium in ICU patients, potentially improving care and outcomes.
Supporting Evidence
- Delirium prevalence in the ICU is high, affecting up to 80% of older patients.
- Older adults with delirium are at higher risk for falls, injuries, and mortality.
- Current treatments for delirium often include potentially harmful medications.
Takeaway
This study is trying to help patients in the ICU who have confusion by using special medicine and support from pharmacists.
Methodology
A randomized controlled trial comparing a multicomponent pharmacological management protocol for delirium against usual care.
Potential Biases
Physicians may change behavior based on exposure to study recommendations.
Limitations
Potential contamination by randomizing at the patient level and the use of low doses of haloperidol.
Participant Demographics
59% African-American and 68% female patients admitted to the ICU.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website